Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
1.030
+0.041 (4.17%)
Aug 26, 2025, 4:00 PM - Market closed
Oncolytics Biotech Market Cap
Oncolytics Biotech has a market cap or net worth of $103.37 million as of August 26, 2025. Its market cap has increased by 36.22% in one year.
Market Cap
103.37M
Enterprise Value
93.30M
1-Year Change
36.22%
Ranking
Category
Stock Price
$1.03
Market Cap Chart
Since October 5, 2001, Oncolytics Biotech's market cap has increased from $96.89M to $103.37M, an increase of 6.69%. That is a compound annual growth rate of 0.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 99.24M | 40.90% |
| Dec 31, 2024 | 70.43M | -28.92% |
| Dec 29, 2023 | 99.09M | 2.98% |
| Dec 30, 2022 | 96.22M | 25.79% |
| Dec 31, 2021 | 76.49M | -25.81% |
| Dec 31, 2020 | 103.10M | -17.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 624.22B |
| Johnson & Johnson | 429.67B |
| AbbVie | 366.65B |
| UnitedHealth Group | 276.10B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 229.51B |